The antihistamine drugs market is estimated to be valued at USD 94.72 Bn in 2024 and is expected to reach USD 154.24 Bn by 2031, growing at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.
To learn more about this report, request sample copy
The antihistamine drugs market has been witnessing a growing trend of development of advanced formulations. Traditionally, antihistamine drugs were available in the form tablets and capsules. However, consumption of tablets and capsules requires water, which may not always be available, especially in outdoor activities involving allergy sufferers.
To overcome this limitation, market players are focusing on developing advanced formulations such as sprays, creams and wipes to provide convenience of use. This has been a major trend revolutionizing use of antihistamines. Development of advanced formulations is expected to drive future growth opportunities in antihistamine drugs market over the forecasted period.
Rising prevalence of allergic diseases
The global prevalence of allergic diseases and disorders has been increasing significantly over the past few decades. Allergic rhinitis, commonly known as hay fever, is a very common medical condition that affects both children and adults. It occurs when the immune system overreacts to allergens in the air like pollen, dust mites, pet dander, or mold. According to an article published by the European government in July 2022, about 150 million people in Europe live with an allergic condition, such as allergic rhinitis, asthma, atopic eczema, or a food allergy. The growing environmental pollution and changes in lifestyle and diet are believed to be major factors contributing to the heightened risk of developing allergic conditions. As antihistamine drugs are currently the most effective pharmacological treatment for relieving symptoms of allergies like sneezing, itchy and watery eyes, it is expected that the rising disease prevalence will drive steady demand for these medications in the coming years.
Increased self-medication practices
Another important driver for the antihistamine drugs market is the trend of self-medication becoming more common among the general public. With easy over-the-counter availability of many common anti-allergy medications without a prescription, people experiencing mild to moderate allergy symptoms often prefer to treat themselves first before seeking medical help. Wide promotion of antihistamine brands directly to consumers through various online and offline advertising campaigns has raised awareness about minor allergy problems and treatment options. This encourages more individuals to reach for an over-the-counter (OTC) antihistamine and try to alleviate their symptoms on their own rather than booking a doctor's appointment. According to an article published in July 2023 by the National Center for Biotechnology Information, a branch of the National Institutes of Health, antihistamines accounted for 13.4% of the total self-medication drugs among the rural population of Tamil Nadu, India.
Global Antihistamine Drugs Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients